Opportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) Era

被引：11
作者：
Moding, Everett J. [1 ,2 ]
Mowery, Yvonne M. [1 ]
Kirsch, David G. [1 ,3 ]
机构：
[1] Duke Univ, Dept Radiat Oncol, Durham, NC USA
[2] Moses Cone Mem Hosp, Dept Internal Med, Greensboro, NC USA
[3] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA
来源：
CANCER JOURNAL | 2016年 / 22卷 / 04期
关键词：
DNA repair; endothelial cells; hypoxia; immune therapy; radiosensitizers; stereotactic body radiation therapy; CANCER STEM-CELLS; TUMOR RESPONSE; IMMUNE-RESPONSES; LOCAL RADIATION; MOUSE MODEL; T-CELLS; RADIOTHERAPY; IMMUNOTHERAPY; INHIBITORS; RADIOBIOLOGY;
D O I：
10.1097/PPO.0000000000000203
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Stereotactic body radiation therapy (SBRT) utilizing a small number of high-dose radiation therapy fractions continues to expand in clinical application. Although many approaches have been proposed to radiosensitize tumors with conventional fractionation, how these radiosensitizers will translate to SBRT remains largely unknown. Here, we review our current understanding of how SBRT eradicates tumors, including the potential contributions of endothelial cell death and immune system activation. In addition, we identify several new opportunities for radiosensitization generated by the move toward high dose per fraction radiation therapy.
引用
收藏
页码：267 / 273
页数：7
相关论文
共 99 条
  • [1] Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature
    Ahn, G-One
    Brown, J. Martin
    [J]. ANGIOGENESIS, 2009, 12 (02) : 159 - 164
  • [2] The history and future of targeting cyclin-dependent kinases in cancer therapy
    Asghar, Uzma
    Witkiewicz, Agnieszka K.
    Turner, Nicholas C.
    Knudsen, Erik S.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (02) : 130 - 146
  • [3] Exploring the role of cancer stem cells in radioresistance
    Baumann, Michael
    Krause, Mechthild
    Hill, Richard
    [J]. NATURE REVIEWS CANCER, 2008, 8 (07) : 545 - 554
  • [4] The determinants of tumour immunogenicity
    Blankenstein, Thomas
    Coulie, Pierre G.
    Gilboa, Eli
    Jaffee, Elizabeth M.
    [J]. NATURE REVIEWS CANCER, 2012, 12 (04) : 307 - 313
  • [5] The Tumor Radiobiology of SRS and SBRT: Are More Than the 5 Rs Involved?
    Brown, J. Martin
    Carlson, David J.
    Brenner, David J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 254 - 262
  • [6] Dose Escalation, Not "New Biology," Can Account for the Efficacy of Stereotactic Body Radiation Therapy With Non-Small Cell Lung Cancer
    Brown, J. Martin
    Brenner, David J.
    Carlson, David J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (05): : 1159 - 1160
  • [7] Brown M, 2003, SCIENCE, V302
  • [8] Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
    Bryant, HE
    Schultz, N
    Thomas, HD
    Parker, KM
    Flower, D
    Lopez, E
    Kyle, S
    Meuth, M
    Curtin, NJ
    Helleday, T
    [J]. NATURE, 2005, 434 (7035) : 913 - 917
  • [9] IMPACT OF STROMAL SENSITIVITY ON RADIATION RESPONSE OF TUMORS
    BUDACH, W
    TAGHIAN, A
    FREEMAN, J
    GIOIOSO, D
    SUIT, HD
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (12) : 988 - 993
  • [10] WEE1 Kinase Inhibition Enhances the Radiation Response of Diffuse Intrinsic Pontine Gliomas
    Caretti, Viola
    Hiddingh, Lotte
    Lagerweij, Tonny
    Schellen, Pepijn
    Koken, Phil W.
    Hulleman, Esther
    van Vuurden, Dannis G.
    Vandertop, W. Peter
    Kaspers, Gertjan J. L.
    Noske, David P.
    Wurdinger, Thomas
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (02) : 141 - 150
12345678910